+39 06 72596393

fismed@uniroma2.it

    Aurelia Fraticelli

    Aurelia Fraticelli

    Dottoranda

    PHYS-06/A - Fisica per le scienze della vita, l'ambiente e i beni culturali

    Email

    aureliafraticelli98@gmail.com

    Phone

    +39 06 72596008

    Biografia

    Ho conseguito la laurea triennale in Biotecnologia per la salute nel 2022 e la laurea magistrale in Biotecnologie mediche in lingua inglese nel 2024 presso l’Università degli Studi di Napoli “Federico II”.

    Durante il periodo di tirocinio magistrale ho lavorato allo sviluppo di un saggio di neutralizzazione sicuro in vitro basato sulla produzione di particelle lentivirali pseudotipizzate con le diverse varianti della spike del SARS-CoV2.

    Il progetto di Dottorato mira allo sviluppo di nuove strategie diagnostiche e terapeutiche per il cancro al pancreas.

    Profili

    Created with Fabric.js 4.6.0

    Scopus

    Orcid

    Pubmed

    Linked In

    Ultimi 5 articoli (Scopus)

    opensearch:totalResults = 3
    opensearch:startIndex = 0
    opensearch:itemsPerPage = 3
    @role = request
    @searchTerms = AU-ID(59963674700)
    @startPage = 0

    @_fa = true
    @ref = self
    @href = https://api.elsevier.com/content/search/scopus?start=0&count=25&query=AU-ID%2859963674700%29&apiKey=6ae70c855c11cca26b94ca23c22dcbcf
    @type = application/json

    @_fa = true
    @ref = first
    @href = https://api.elsevier.com/content/search/scopus?start=0&count=25&query=AU-ID%2859963674700%29&apiKey=6ae70c855c11cca26b94ca23c22dcbcf
    @type = application/json


    inizio

    @_fa = true

    @_fa = true
    @ref = self
    @href = https://api.elsevier.com/content/abstract/scopus_id/105011770350

    @_fa = true
    @ref = author-affiliation
    @href = https://api.elsevier.com/content/abstract/scopus_id/105011770350?field=author,affiliation

    @_fa = true
    @ref = scopus
    @href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105011770350&origin=inward

    @_fa = true
    @ref = scopus-citedby
    @href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105011770350&origin=inward

    Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation; Cellular and Molecular Life Sciences; December 2025; DOI: 10.1007/s00018-025-05781-y
    prism:url = https://api.elsevier.com/content/abstract/scopus_id/105011770350
    dc:identifier = SCOPUS_ID:105011770350
    eid = 2-s2.0-105011770350
    dc:creator = De Luca G.
    prism:publicationName = Cellular and Molecular Life Sciences
    prism:issn = 1420682X
    prism:eIssn = 14209071
    prism:volume = 82
    prism:issueIdentifier = 1
    prism:pageRange =
    prism:coverDate = 2025-12-01
    prism:coverDisplayDate = December 2025
    prism:doi = 10.1007/s00018-025-05781-y
    citedby-count = 1

    @_fa = true
    affilname = Consiglio Nazionale delle Ricerche
    affiliation-city = Rome
    affiliation-country = Italy

    pubmed-id = 40711489
    prism:aggregationType = Journal
    subtype = ar
    subtypeDescription = Article
    article-number = 287
    source-id = 13903
    openaccess = 1
    openaccessFlag = true
    value:

    $ = all

    $ = publisherfullgold

    $ = repository

    $ = repositoryam

    value:

    $ = All Open Access

    $ = Gold

    $ = Green

    prism:isbn:

    @_fa =
    $ =

    pii =

    inizio

    @_fa = true

    @_fa = true
    @ref = self
    @href = https://api.elsevier.com/content/abstract/scopus_id/105017247775

    @_fa = true
    @ref = author-affiliation
    @href = https://api.elsevier.com/content/abstract/scopus_id/105017247775?field=author,affiliation

    @_fa = true
    @ref = scopus
    @href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105017247775&origin=inward

    @_fa = true
    @ref = scopus-citedby
    @href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105017247775&origin=inward

    @_fa = true
    @ref = full-text
    @href = https://api.elsevier.com/content/article/eid/1-s2.0-S2473952925003817

    BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma; Blood Advances; 14 October 2025; DOI: 10.1182/bloodadvances.2024015322
    prism:url = https://api.elsevier.com/content/abstract/scopus_id/105017247775
    dc:identifier = SCOPUS_ID:105017247775
    eid = 2-s2.0-105017247775
    dc:creator = Pignataro C.
    prism:publicationName = Blood Advances
    prism:issn = 24739529
    prism:eIssn = 24739537
    prism:volume = 9
    prism:issueIdentifier = 19
    prism:pageRange = 4757-4775
    prism:coverDate = 2025-10-14
    prism:coverDisplayDate = 14 October 2025
    prism:doi = 10.1182/bloodadvances.2024015322
    citedby-count = 1

    @_fa = true
    affilname = Università degli Studi di Napoli Federico II
    affiliation-city = Naples
    affiliation-country = Italy

    pubmed-id = 40601898
    prism:aggregationType = Journal
    subtype = ar
    subtypeDescription = Article
    article-number =
    source-id = 21100886825
    openaccess = 1
    openaccessFlag = true
    value:

    $ = all

    $ = publisherfullgold

    $ = repository

    $ = repositoryam

    value:

    $ = All Open Access

    $ = Gold

    $ = Green

    prism:isbn:

    @_fa =
    $ =

    pii =

    inizio

    @_fa = true

    @_fa = true
    @ref = self
    @href = https://api.elsevier.com/content/abstract/scopus_id/105009081646

    @_fa = true
    @ref = author-affiliation
    @href = https://api.elsevier.com/content/abstract/scopus_id/105009081646?field=author,affiliation

    @_fa = true
    @ref = scopus
    @href = https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105009081646&origin=inward

    @_fa = true
    @ref = scopus-citedby
    @href = https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105009081646&origin=inward

    Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment; Biomolecules; June 2025; DOI: 10.3390/biom15060768
    prism:url = https://api.elsevier.com/content/abstract/scopus_id/105009081646
    dc:identifier = SCOPUS_ID:105009081646
    eid = 2-s2.0-105009081646
    dc:creator = Affinito A.
    prism:publicationName = Biomolecules
    prism:issn =
    prism:eIssn = 2218273X
    prism:volume = 15
    prism:issueIdentifier = 6
    prism:pageRange =
    prism:coverDate = 2025-06-01
    prism:coverDisplayDate = June 2025
    prism:doi = 10.3390/biom15060768
    citedby-count = 1

    @_fa = true
    affilname = Università degli Studi di Napoli Federico II
    affiliation-city = Naples
    affiliation-country = Italy

    @_fa = true
    affilname = AKA Biotech
    affiliation-city = Naples
    affiliation-country = Italy

    pubmed-id = 40563410
    prism:aggregationType = Journal
    subtype = ar
    subtypeDescription = Article
    article-number = 768
    source-id = 21100394188
    openaccess = 1
    openaccessFlag = true
    value:

    $ = all

    $ = publisherfullgold

    $ = repository

    $ = repositoryam

    value:

    $ = All Open Access

    $ = Gold

    $ = Green

    prism:isbn:

    @_fa =
    $ =

    pii =

    Ultimi 5 articoli (PubMed)

    • Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation
      on 25 Luglio 2025

      The intricate interplay between epithelial and fibroblast cells within the tumor microenvironment plays a crucial role in driving triple-negative breast cancer progression. This crosstalk involves the exchange of various signaling molecules, including growth factors, cytokines, extracellular matrix components, and extracellular vesicles. Recently, we demonstrated that triple-negative breast cancer extracellular vesicles carry and release a specific combination of miRs, including miR-185-5p,...

    • BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma
      on 2 Luglio 2025

      Resistance to first-line chemotherapies and crizotinib in anaplastic large cell lymphoma (ALCL) represents a significant challenge, often leading to a dismal outcome. Despite recent advancements, the dissection of the intrinsic and extrinsic molecular alterations underlying crizotinib resistance in ALCL is still poorly understood. Here, we transcriptionally unraveled the bidirectional interplay between anaplastic lymphoma kinase (ALK)-driven ALCL (ALK+ ALCL) and stromal cells in the presence of...

    • Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment
      on 26 Giugno 2025

      Glioblastoma (GBM) is the most aggressive and challenging brain cancer, in terms of diagnosis and therapy. The highly infiltrative glioblastoma stem cells (GSCs) are difficult to visualize and surgically remove with the current diagnostic tools, which often lead to misdiagnosis and false-positive results. In this study, we focused on a groundbreaking tool for specifically visualizing and removing GSCs. We exploited the specific binding of A40s aptamer to EphA2 for the selective delivery of...

    CONTATTI

    Orario Segreteria

    • Lun-Ven 09:00-15:00

    collegamenti

    Facebook Twitter Instagram

    Sito creato da An:Ca © 2025 Università di Roma Tor Vergata P.I. 02133971008 – C.F. 80213750583